Article Information
History
- November 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sedona Sweeney, PhD1,*,
- Catherine Berry, BMed2,
- Emil Kazounis, MMedSci2,
- Ilaria Motta, PhD2,
- Anna Vassall, PhD1,
- Matthew Dodd, MSc3,
- Katherine Fielding, PhD3 and
- Bern-Thomas Nyang’wa, MBBS4,5
- 1Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London UK
- 2Public Health Department OCA, Médecins Sans Frontières, UK
- 3Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London UK
- 4Public Health Department OCA, Médecins Sans Frontières, the Netherlands
- 5Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London UK
- ↵*Corresponding author: Sedona Sweeney, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, Email: sedona.sweeney{at}lshtm.ac.uk, Tel: +44 207 927 2890
Posted November 10, 2022.
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis
